The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults.
about
Community acquired bacterial pneumoniaFormulation, characterization and physicochemical evaluation of amoxicillin effervescent tablets.Current treatment of community-acquired pneumonia.Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
P2860
The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The development of pharmacokin ...... ry tract infections in adults.
@en
The development of pharmacokin ...... ry tract infections in adults.
@nl
type
label
The development of pharmacokin ...... ry tract infections in adults.
@en
The development of pharmacokin ...... ry tract infections in adults.
@nl
prefLabel
The development of pharmacokin ...... ry tract infections in adults.
@en
The development of pharmacokin ...... ry tract infections in adults.
@nl
P1476
The development of pharmacokin ...... ry tract infections in adults.
@en
P2093
Thomas M File
P304
P356
10.1016/J.IJANTIMICAG.2007.07.038
P478
30 Suppl 2
P577
2007-12-01T00:00:00Z